Call for Proposals

Abstract submissions may be proposed for any of the following: 

1. Oral Presentation
   • 20-30-minute presentation, including Q&A. The presentation should focus on new and innovative trends, a specific real-world strategy or campaign, a case study/use case, or a “how-to" presentation intended to help attendees gain a better understanding of the initiative and best practices that can be applied to day-to-day objectives or overall mission.

The 2025 Biotechnology Conference program committee is requesting proposals aligning with the following content areas:

1. Accelerating Biopharma with AI & ML: From Discovery to Delivery

This track will explore how Artificial Intelligence (AI) and Machine Learning (ML) are driving real change in biotechnology, from drug development to manufacturing and beyond. As the industry moves towards more complex products like biosimilars, bio betters, cell and gene therapies, ATMPs, and mRNA-based treatments, AI and ML are becoming critical tools for speeding up process development, improving manufacturing efficiency, and reducing time to market. We'll dive into practical applications, including how these technologies are enabling smarter control strategies and smoother technology transfers, while also addressing challenges like sustainability, scalability, and regulatory requirements. This is where biotechnology meets the future—reshaping the way we approach therapeutic innovation.

2. Process Intensification, Continuous Manufacturing, Sustainability

Companies are adopting sustainability approaches, process intensification, and continuous manufacturing to improve efficiency and decrease the impact on our environment.

The sustainability approach can decrease the amount of energy consumption, water and material usage, and generated waste products. Process intensification aims to increase product output relative to time, cost, reactor or manufacturing volumes, and inputs of materials. Continuous manufacturing is an approach used to improve productivity, reduce plant footprint and capital and operational expenses, and potentially alleviate product shortages.

These approaches have some shared advantages over traditional manufacturing approaches. The session will explain success stories.

3. Operational Readiness and Cultural Excellence

In today's fast-changing world, companies face the challenge of staying up to date with new technologies while ensuring their teams have the right skills to effectively maintain operations. Being flexible across all areas of a business is key to driving innovation. The same principle applies to learning and workforce advancement.

This track focuses on the importance of improving processes, upgrading employee skills, and fostering innovation to guarantee operational readiness amid an evolving industry. Sessions will cover how companies are improving systems to handle new challenges, with an emphasis on keeping operations agile and innovative. It will also highlight how companies are training their teams to successfully work with new systems and improved processes in order to ensure long-term success.

4. Biomanufacturing Facility Lifecycle: Progress, Trends and Challenges

Current Good Manufacturing Practices (cGMP) exist for a sole reason: to protect the quality and integrity of the final drug product and inevitably ensure patient safety. This approach will never change. However, the driver for continuous improvement to uphold product quality will continue to progress.

Join us for an engaging track in exploring the key drivers behind the lifecycle of biomanufacturing facility design from the lens of progress, trends, and challenges. These factors collectively influence the design, operation, and evolution of biomanufacturing facilities, ensuring they can meet current and future production needs while maintaining high standards of quality and efficiency.

5. Analytical Enhanced Quality

In today’s data-driven world, the pursuit of quality has evolved beyond traditional methods. This track explores the innovative intersection of analytics and quality management, with a particular focus on the biotech industry. Topics may include advanced analytical techniques such as machine learning, predictive analytics, and big data. Additionally, this track will provide space for discussions on moving beyond analytics and incorporating new technologies to improve efficiency and speed to market. We will explore the impact of these technologies on the workforce of today and the workforce of the future.

6. Implementing Digital Initiatives in the Biopharmaceutical Industry - Where are we on the Road Map?

With the evolving digital landscape in the biopharmaceutical industry, this track aims to provide an insightful overview of the current state of digital transformation and Pharma 4.0 initiatives. Companies are increasingly piloting and integrating advanced technologies such as cloud computing, artificial intelligence (AI), data lakes, and virtual reality (VR) into their operations; however, challenges still exist when working with legacy systems, data silos, and compliance concerns.

This track will delve into best practices for company-wide deployment of digital initiatives, highlighting successful case studies and overcoming common challenges during the scale-up of digital transformations. The emphasis will be placed on creating cohesive strategies that align digital initiatives with organizational goals and regulatory frameworks.

We will also explore the essential aspects of digital validation approaches, examining how companies can ensure the reliability and regulatory compliance of digital tools and platforms.

Additionally, the track will cover innovative digital knowledge and data management strategies. We will discuss how companies can effectively manage vast amounts of data (generated from sources with varying degrees of integration) to drive decision-making, improve operational efficiency, and foster a culture of continuous improvement. The implementation of robust data governance practices and advanced analytics will be highlighted as critical components to achieving success in a digital environmen

• All presentations must be free of commercial intent. Incomplete proposals will not be considered.
• By submitting a proposal, you acknowledge that, if your proposal is accepted, the speaker will attend/present in-person and the speaker’s attendance at the event will be supported by their organization.
• Accepted speakers are responsible for their own travel and accommodations.
• Speakers giving at least a 20-minute presentation (not including Q&A) receive complimentary conference registration.
• NOTE: Exhibitors who are accepted to present are required to register as a paid conference attendee (with discounted registration rate). Complimentary booth staffing registrations cannot be utilized for the presentations as these are part of the education sessions and not the exhibition.
• Consulting firms or vendors/suppliers are expected to include a speaker from an owner company to present.
• Regulators interested in submitting a proposal: Please contact Brandy Berry to submit your abstract.